CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $6.09B, above the global median of $1.18B
- FinancialsAltman Z-Score 4.43: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.29%
Annual Rate
USD 0.06Paid annual
Payout Ratio
11.0%Sustainable
Consecutive Growth
1 yr
Paying Dividends
5 yr
Last Ex-Dividend
Jun 11, 2026
Last Payment
Jul 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.09BUSDvs all stocks (USD)
Trailing P/E
38.28xvs Medical Instruments & Supplies peers
Revenue (TTM)
1.43BEURvs all stocks (USD)
Profit Margin
10.99%vs Medical Instruments & Supplies peers
Beta
0.7370xvs all stocks
52-Week Change
-6.13%vs all stocks
Market Capitalization
6.09BUSDvs all stocks (USD)
Enterprise Value
7.52BUSDvs all stocks (USD)
Trailing P/E
38.28xvs Medical Instruments & Supplies peers
Forward P/E
25.97xvs Medical Instruments & Supplies peers
PEG Ratio
-1.40xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
4.86xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
3.32xvs Medical Instruments & Supplies peers
Enterprise to Revenue
5.27xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
21.61xvs Medical Instruments & Supplies peers
Gross Margin
28.75%vs Medical Instruments & Supplies peers
Profit Margin
10.99%vs Medical Instruments & Supplies peers
Operating Margin
17.22%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
5.45%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
9.13%vs Medical Instruments & Supplies peers
Revenue (TTM)
1.43BEURvs all stocks (USD)
Revenue per Share (TTM)
4.49EURUpdated Aug 28, 2026Quarterly Revenue Growth
7.80%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
419.59MEURvs all stocks (USD)
EBITDA (TTM)
263.30MEURvs all stocks (USD)
Net Income (TTM)
156.80MEURvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-22.70%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
289.67MEURvs all stocks (USD)
Levered Free Cash Flow (TTM)
-121.96MEURvs all stocks (USD)
Trailing Annual Dividend Rate
0.0620USDUpdated Aug 28, 2026Trailing Annual Dividend Yield
0.29%vs all stocks
Payout Ratio
11.02%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
38.00KEURFY2025 · Dec 31, 2025Revenue
1.19BEURFY2025 · Dec 31, 2025Cost of Goods Sold
842.41MEURFY2025 · Dec 31, 2025Gross Profit
343.88MEURFY2025 · Dec 31, 2025Operating Income
198.80MEUR231.61M · vs all stocks (USD)
Pre-tax Income
189.11MEURFY2025 · Dec 31, 2025Income Tax Expense
49.27MEURFY2025 · Dec 31, 2025Net Income
139.83MEURFY2025 · Dec 31, 2025EBIT
195.59MEURFY2025 · Dec 31, 2025EBITDA (Income Statement)
288.08MEURFY2025 · Dec 31, 2025Research & Development
25.44MEURFY2025 · Dec 31, 2025Selling, General & Administrative
119.06MEURFY2025 · Dec 31, 2025Other Operating Expenses
-8.24MEURFY2025 · Dec 31, 2025Non-operating Interest Income
1.03MEURFY2025 · Dec 31, 2025Non-operating Interest Expense
6.48MEURFY2025 · Dec 31, 2025EPS (Basic)
0.5100EURFY2025 · Dec 31, 2025EPS (Diluted)
0.5100EURFY2025 · Dec 31, 2025Basic Shares Outstanding
272.95MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
272.95MSharesFY2025 · Dec 31, 2025Minority Interests (P&L)
8.00KEURFY2025 · Dec 31, 2025Operating Cash Flow
349.08MEURFY2025 · Dec 31, 2025Free Cash Flow
87.19MEURFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
130.60MEURFY2025 · Dec 31, 2025Starting Profit (CF Statement)
189.11MEURFY2025 · Dec 31, 2025Depreciation & Amortization
88.57MEURFY2025 · Dec 31, 2025Other Non-cash Items
20.79MEURFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
891.00KEURFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
91.19MEURFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-41.45MEURFY2025 · Dec 31, 2025Capital Expenditures
-261.90MEURFY2025 · Dec 31, 2025Net Intangibles (CF)
-11.28MEURFY2025 · Dec 31, 2025Net Acquisitions
0.00EURFY2025 · Dec 31, 2025Net Investing Cash Flow
-261.90MEURFY2025 · Dec 31, 2025Long-term Debt Issuance
150.00MEURFY2025 · Dec 31, 2025Long-term Debt Payments
-113.20MEURFY2025 · Dec 31, 2025Common Dividends Paid
-14.74MEURFY2025 · Dec 31, 2025Net Financing Cash Flow
22.06MEURFY2025 · Dec 31, 2025Shares Outstanding
273.13MSharesUpdated Aug 28, 2026Float Shares
49.03MSharesUpdated Aug 28, 2026Shares Short
1.03MSharesUpdated Aug 28, 2026Short Ratio
2.55daysvs all stocks
Short % of Shares Outstanding
2.09%vs all stocks
% Held by Insiders
1.64%vs all stocks
% Held by Institutions
97.04%vs all stocks
Total Cash (MRQ)
92.19MEURvs all stocks (USD)
Total Cash per Share (MRQ)
0.2900EURUpdated Aug 28, 2026Total Debt (MRQ)
518.71MEURvs all stocks (USD)
Total Debt to Equity (MRQ)
0.2873xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.61xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
6.57EURUpdated Aug 28, 2026Total Assets
2.54BEUR2.96B · vs all stocks (USD)
Total Current Assets
943.35MEURFY2025 · Dec 31, 2025Total Liabilities
1.06BEURFY2025 · Dec 31, 2025Total Non-current Assets
1.60BEURFY2025 · Dec 31, 2025Total Non-current Liabilities
521.58MEURFY2025 · Dec 31, 2025Total Current Liabilities
535.88MEURFY2025 · Dec 31, 2025Cash & Cash Equivalents
130.60MEURFY2025 · Dec 31, 2025Accounts Receivable
302.69MEURFY2025 · Dec 31, 2025Inventory
268.25MEURFY2025 · Dec 31, 2025Accounts Payable
263.31MEURFY2025 · Dec 31, 2025Short-term Debt
121.75MEURFY2025 · Dec 31, 2025Deferred Revenue
56.97MEURFY2025 · Dec 31, 2025Other Current Liabilities
9.24MEURFY2025 · Dec 31, 2025Long-term Debt
347.16MEURFY2025 · Dec 31, 2025Other Non-current Liabilities
52.16MEURFY2025 · Dec 31, 2025Common Stock (Book)
22.23MEURFY2025 · Dec 31, 2025Retained Earnings
990.43MEURFY2025 · Dec 31, 2025Total Shareholders' Equity
1.49BEUR1.73B · vs all stocks (USD)
Treasury Stock
27.08MEURFY2025 · Dec 31, 202552-Week Low
12.89USDUpdated Aug 28, 202652-Week High
28.00USDUpdated Aug 28, 202652-Week Change
-6.13%vs all stocks
Beta
0.7370xvs all stocks
50-Day MA
19.84USDUpdated Aug 28, 2026200-Day MA
18.39USDUpdated Aug 28, 2026Avg 10-Day Volume
494.20KSharesUpdated Aug 28, 2026Avg 30-Day Volume
448.31KSharesUpdated Aug 28, 2026Diluted EPS (TTM)
0.5700EURUpdated Aug 28, 2026Other Income / Expense
-3.93MEURFY2025 · Dec 31, 2025Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 4.43: safe zoneNotable
Altman Z-Score: 4.43
High earnings qualityNotable
Earnings Quality Score: 0.56
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $6.09B, above the global median of $1.18BNotable
Market cap (USD): 6,087,982,376Global Median: 1,179,398,897.704
Revenue is $1.43B, above the global median of $534.05MNotable
Revenue (USD): 1,427,205,680Global Median: 534,052,387.958
Companies that share the same coordination system — how they create, deliver, or capture value.
Kodiak Gas Services Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
T&S Communications Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shanghai Bochuan Electronic Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
CNOOC Energy Technology & Services Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Hangzhou First Applied Material Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Galaxycore Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Brookfield Renewable Corporation
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Saudi Aramco Base Oil Company
Tier 1ProductionThroughput-Bound ConversionFlowRule
Orbbee Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Bausch + Lomb Corporation
Tier 1ProductionThroughput-Bound ConversionRule